Rwanda to Begin Clinical Trials for Marburg Virus Disease

Rwanda is gearing up to commence vaccine and therapeutic clinical trials to combat the Marburg virus disease, following a recent outbreak in the country. Health State Minister Yvan Butera announced the plans, emphasizing the importance of collaboration to contain the spread.

The World Health Organization (WHO) Rwanda country representative, Brian Chilombo, highlighted Rwanda’s readiness to participate in clinical trials, alongside 16 other African countries. The aim is to test potential vaccines and therapeutics to combat the deadly virus.

Since the outbreak last month, Rwanda has reported 36 cases and 11 deaths. Efforts are underway to isolate and treat affected individuals, with strict measures in place to prevent further transmission. The Health Ministry is closely monitoring contacts and conducting necessary tests.

The Marburg virus, with a high fatality ratio similar to Ebola, causes severe symptoms such as high fever, headaches, and hemorrhaging. It is essential to take preventive measures and conduct research to develop effective treatments.

Stay tuned for updates on Rwanda’s clinical trials and efforts to combat the Marburg virus.

[ad_2]

Source link